메뉴 건너뛰기




Volumn 12, Issue 11, 2010, Pages 885-888

Distinguishing between restoration and enhancement in neuropharmacology

Author keywords

[No Author keywords available]

Indexed keywords


EID: 78650786776     PISSN: 19377010     EISSN: None     Source Type: Journal    
DOI: 10.1001/virtualmentor.2010.12.11.msoc1-1011     Document Type: Article
Times cited : (11)

References (10)
  • 1
    • 34249104258 scopus 로고    scopus 로고
    • Brave neuro world
    • January
    • Schulz K. Brave neuro world. The Nation. January 9, 2006:11-16.
    • (2006) The Nation , vol.9 , pp. 11-16
    • Schulz, K.1
  • 2
    • 4644325547 scopus 로고    scopus 로고
    • Cosmetic neurology: The controversy over enhancing movement, mentation, and mood
    • Chatterjee A. Cosmetic neurology: the controversy over enhancing movement, mentation, and mood. Neurology. 2004;63(6):968-974.
    • (2004) Neurology , vol.63 , Issue.6 , pp. 968-974
    • Chatterjee, A.1
  • 3
    • 70350560786 scopus 로고    scopus 로고
    • Responding to requests from adult patients for neuroenhancements. Guidance of the ethics, law and humanities committee
    • Larriviere D, Williams MA, Rizzo M, Bonnie RJ; AAN Ethics, Law and Humanities Committee. Responding to requests from adult patients for neuroenhancements. Guidance of the Ethics, Law and Humanities Committee. Neurology. 2009;73(17):1406-1412.
    • (2009) Neurology , vol.73 , Issue.17 , pp. 1406-1412
    • Larriviere, D.1    Williams, M.A.2    Rizzo, M.3    Bonnie, R.J.4
  • 4
    • 0032082710 scopus 로고    scopus 로고
    • The internal morality of medicine: Explication and application to managed care
    • Brody H, Miller F. The internal morality of medicine: explication and application to managed care. J Med Philos. 1998;23(4):384-410.
    • (1998) J Med Philos , vol.23 , Issue.4 , pp. 384-410
    • Brody, H.1    Miller, F.2
  • 5
    • 70350510661 scopus 로고    scopus 로고
    • Going off-label without venturing off-course: Evidence and ethical off-label prescribing
    • Largent EA, Miller FG, Pearson SD. Going off-label without venturing off-course: evidence and ethical off-label prescribing. Arch Intern Med. 2009;169(19):1745-1747.
    • (2009) Arch Intern Med , vol.169 , Issue.19 , pp. 1745-1747
    • Largent, E.A.1    Miller, F.G.2    Pearson, S.D.3
  • 6
    • 2342632575 scopus 로고    scopus 로고
    • Neurocognitive enhancement: What can we do and what should we do?
    • Farah MJ, Illes J, Cook-Deegan R, et al. Neurocognitive enhancement: what can we do and what should we do? Nat Rev Neurosci. 2004;5(5):421-425.
    • (2004) Nat Rev Neurosci , vol.5 , Issue.5 , pp. 421-425
    • Farah, M.J.1    Illes, J.2    Cook-Deegan, R.3
  • 7
    • 57649136894 scopus 로고    scopus 로고
    • Towards responsible use of cognitive-enhancing drugs by the healthy
    • Greely H, Sahakian B, Harris J, et al. Towards responsible use of cognitive-enhancing drugs by the healthy. Nature. 2008;456(7223):702-705.
    • (2008) Nature , vol.456 , Issue.7223 , pp. 702-705
    • Greely, H.1    Sahakian, B.2    Harris, J.3
  • 8
    • 84927084331 scopus 로고
    • Age-associated memory impairment: Proposed diagnostic criteria and measures of clinical change-report of a national institute of mental health work group
    • Crook T, Bartus RT, Ferris SH, Whitehouse P, Cohen GD, Gershon S. Age-associated memory impairment: Proposed diagnostic criteria and measures of clinical change-report of a national institute of mental health work group. Dev Neuropsych. 1986;2(4):261-276.
    • (1986) Dev Neuropsych , vol.2 , Issue.4 , pp. 261-276
    • Crook, T.1    Bartus, R.T.2    Ferris, S.H.3    Whitehouse, P.4    Cohen, G.D.5    Gershon, S.6


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.